VPH vs. CTX, WLLW, DN, LABS, TMD, and ATE
Should you be buying Valeo Pharma stock or one of its competitors? The main competitors of Valeo Pharma include Crescita Therapeutics (CTX), Willow Biosciences (WLLW), Delta 9 Cannabis (DN), MediPharm Labs (LABS), Titan Medical (TMD), and Antibe Therapeutics (ATE). These companies are all part of the "medical" sector.
Crescita Therapeutics (TSE:CTX) and Valeo Pharma (TSE:VPH) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.
Crescita Therapeutics received 59 more outperform votes than Valeo Pharma when rated by MarketBeat users. However, 100.00% of users gave Valeo Pharma an outperform vote while only 67.42% of users gave Crescita Therapeutics an outperform vote.
Crescita Therapeutics has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, Valeo Pharma has a beta of 2.53, suggesting that its stock price is 153% more volatile than the S&P 500.
Crescita Therapeutics has a net margin of -11.33% compared to Crescita Therapeutics' net margin of -52.37%. Crescita Therapeutics' return on equity of 0.00% beat Valeo Pharma's return on equity.
Crescita Therapeutics has higher earnings, but lower revenue than Valeo Pharma. Crescita Therapeutics is trading at a lower price-to-earnings ratio than Valeo Pharma, indicating that it is currently the more affordable of the two stocks.
7.2% of Valeo Pharma shares are owned by institutional investors. 10.4% of Crescita Therapeutics shares are owned by insiders. Comparatively, 47.1% of Valeo Pharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
In the previous week, Crescita Therapeutics had 1 more articles in the media than Valeo Pharma. MarketBeat recorded 1 mentions for Crescita Therapeutics and 0 mentions for Valeo Pharma. Valeo Pharma's average media sentiment score of 0.00 equaled Crescita Therapeutics'average media sentiment score.
Summary
Crescita Therapeutics and Valeo Pharma tied by winning 7 of the 14 factors compared between the two stocks.
Get Valeo Pharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for VPH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Valeo Pharma Competitors List
Related Companies and Tools
